Guru Ownership Trend
Guru Analysis for Neurocrine Biosciences, Inc. (NBIX)
Neurocrine Biosciences, Inc. (NBIX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.26 B.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $265.01 M net inflow during the quarter.
Recent activity highlights Jeremy Grantham who increased their stake by 399.5%. Conversely, Jefferies Group reduced exposure by 93.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Neurocrine Biosciences, Inc. (NBIX)
Major holders include Cliff Asness ($650.66 M), Renaissance Technologies (RenTech) ($318.67 M), Joel Greenblatt ($47.44 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 8.05 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $265.01 M, with 5 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited NBIX. The total reported sell value was $8.67 M.
Yes, 0 managers opened new positions in NBIX, and 5 increased their existing holdings. The total reported buy value was $273.68 M.
